These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 34215644
1. Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis. Ocon AJ, Reed G, Pappas DA, Curtis JR, Kremer JM. Ann Rheum Dis; 2021 Dec; 80(12):1522-1529. PubMed ID: 34215644 [Abstract] [Full Text] [Related]
3. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. del Rincón I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A. Arthritis Rheumatol; 2014 Feb; 66(2):264-72. PubMed ID: 24504798 [Abstract] [Full Text] [Related]
4. Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study. So H, Lam TO, Meng H, Lam SHM, Tam LS. Ann Rheum Dis; 2023 Nov; 82(11):1387-1393. PubMed ID: 37487608 [Abstract] [Full Text] [Related]
5. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study. Solomon DH, Greenberg J, Curtis JR, Liu M, Farkouh ME, Tsao P, Kremer JM, Etzel CJ. Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470 [Abstract] [Full Text] [Related]
6. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. Arts EE, Fransen J, den Broeder AA, Popa CD, van Riel PL. Ann Rheum Dis; 2015 Jun; 74(6):998-1003. PubMed ID: 24458537 [Abstract] [Full Text] [Related]
7. Preadmission use of glucocorticoids and risk of cardiovascular events in patients with ischemic stroke. Sundbøll J, Darvalics B, Horváth-Puhó E, Adelborg K, Laugesen K, Schmidt M, Henderson VW, Sørensen HT. J Thromb Haemost; 2018 Nov; 16(11):2175-2183. PubMed ID: 30179297 [Abstract] [Full Text] [Related]
13. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Kirwan JR, Bijlsma JW, Boers M, Shea BJ. Cochrane Database Syst Rev; 2007 Jan 24; 2007(1):CD006356. PubMed ID: 17253590 [Abstract] [Full Text] [Related]
14. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Innala L, Möller B, Ljung L, Magnusson S, Smedby T, Södergren A, Öhman ML, Rantapää-Dahlqvist S, Wållberg-Jonsson S. Arthritis Res Ther; 2011 Aug 15; 13(4):R131. PubMed ID: 21843325 [Abstract] [Full Text] [Related]
15. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Naranjo A, Sokka T, Descalzo MA, Calvo-Alén J, Hørslev-Petersen K, Luukkainen RK, Combe B, Burmester GR, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Tunc R, Dimic A, Bergman M, Toloza S, Pincus T, QUEST-RA Group. Arthritis Res Ther; 2008 Aug 15; 10(2):R30. PubMed ID: 18325087 [Abstract] [Full Text] [Related]
16. Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis. Cacciapaglia F, Fornaro M, Venerito V, Perniola S, Urso L, Iannone F. Eur J Clin Invest; 2020 Dec 15; 50(12):e13343. PubMed ID: 32654116 [Abstract] [Full Text] [Related]
17. Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early rheumatoid arthritis. Roubille C, Coffy A, Rincheval N, Dougados M, Flipo RM, Daurès JP, Combe B. Rheumatology (Oxford); 2021 Aug 02; 60(8):3738-3746. PubMed ID: 33320245 [Abstract] [Full Text] [Related]
19. Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis. Johnson TM, Sayles HR, Baker JF, George MD, Roul P, Zheng C, Sauer B, Liao KP, Anderson DR, Mikuls TR, England BR. Ann Rheum Dis; 2021 Nov 02; 80(11):1385-1392. PubMed ID: 34049859 [Abstract] [Full Text] [Related]
20. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. Pujades-Rodriguez M, Morgan AW, Cubbon RM, Wu J. PLoS Med; 2020 Dec 02; 17(12):e1003432. PubMed ID: 33270649 [Abstract] [Full Text] [Related] Page: [Next] [New Search]